iOmx Therapeutics AG

📍 Martinsried/Munich, Germany🗓 Founded 2016👥 40 employees💰 Last funded Jun 2018
Pharmaceutical Manufacturing🌐 iomx.com
Website LinkedIn
iOmx is a young, dynamic start-up in the field of immuno-oncology located in Martinsried/Munich, Germany. Backed by a powerful technology platform and internationally renowned investors, iOmx is driving forward a cutting-edge portfolio of early-stage novel immune-checkpoint drugs through pre-clinical and clinical development. Imprint: https://iomx.com/imprint
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Belgium
1
Netherlands
1
Germany
1
Investor activity2016–2018 · investors recorded per year
2016220181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in iOmx Therapeutics AG?
iOmx Therapeutics AG has 3 investors on record on gritt.io, including 3 early-stage backers.
When did iOmx Therapeutics AG last raise funding?
The most recent investment in iOmx Therapeutics AG recorded on gritt.io was in June 2018.
When was iOmx Therapeutics AG founded?
iOmx Therapeutics AG was founded in 2016.
What industry is iOmx Therapeutics AG in?
iOmx Therapeutics AG operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is iOmx Therapeutics AG based?
iOmx Therapeutics AG is headquartered in Martinsried/Munich, Germany.